Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
2
25%
Ph phase_2
1
13%
Ph phase_4
4
50%

Phase Distribution

2

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 44 (50.0%)
N/A1 (12.5%)

Trials by Status

completed675%
terminated225%

Recent Activity

0 active trials
Showing 5 of 8
completednot_applicable

Efficacy of Long Term Plavix Therapy Post Angioplasty

NCT02327741
completedphase_1

Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation

NCT01860105
completedphase_4

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

NCT01349777
terminatedphase_2

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

NCT00263211
terminatedphase_4

Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01339026
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02327741Not Applicable

Efficacy of Long Term Plavix Therapy Post Angioplasty

Completed
NCT01860105Phase 1

Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation

Completed
NCT01349777Phase 4

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Completed
NCT00263211Phase 2

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

Terminated
NCT01339026Phase 4

Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention

Terminated
NCT01147133Phase 4

Comparison of Generic and Original Formulation of Clopidogrel

Completed
NCT01431495Phase 4

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

Completed
NCT00620802Phase 1

Pharmacodynamics of CGT 2168 Compared With Plavix®

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8